These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36536185)

  • 1. Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2.
    Khandelwal V; Sharma T; Gupta S; Singh S; Sharma MK; Parashar D; Kashyap VK
    Mol Biol Rep; 2023 Mar; 50(3):2663-2683. PubMed ID: 36536185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
    Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.
    Du J; Li H; Lian J; Zhu X; Qiao L; Lin J
    Stem Cell Res Ther; 2020 May; 11(1):192. PubMed ID: 32448377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.
    Chrzanowski W; Kim SY; McClements L
    Front Bioeng Biotechnol; 2020; 8():554. PubMed ID: 32574317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
    Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
    J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.
    Raghav A; Khan ZA; Upadhayay VK; Tripathi P; Gautam KA; Mishra BK; Ahmad J; Jeong GB
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19.
    Ibrahim C; Semaan H; El-Sabban M; Najjar F; Hamade A
    Curr Mol Med; 2021; 21(6):441-456. PubMed ID: 33208076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
    J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
    Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
    Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol.
    Wang S; Li W; Hui H; Tiwari SK; Zhang Q; Croker BA; Rawlings S; Smith D; Carlin AF; Rana TM
    EMBO J; 2020 Nov; 39(21):e106057. PubMed ID: 32944968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine in the management of Covid-19: With or lieu of evidence.
    Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection.
    Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK
    mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.